From: Prognostic significance of histological invasion in high grade soft tissue sarcomas
Factors | No. of patients | Overall 5-year survival rate | P-value | Event free 5-year survival rate | P-value | Local recurrence free 5-year survival rate | P-value |
---|---|---|---|---|---|---|---|
Age | |||||||
≧60 yr | 56 | 80.8% | p = 0.298 | 64.4% | p = 0.711 | 87.0% | p = 0.926 |
<60 yr | 77 | 84.5% | 62.0% | 86.5% | |||
Gender | |||||||
Male | 78 | 78.7% | p = 0.362 | 55.4% | p = 0.067 | 96.3% | p = 0.040 * |
Female | 55 | 86.9% | 75.8% | 80.5% | |||
Tumor location | |||||||
Extremity | 108 | 83.4% | p = 0.271 | 64.9% | p = 0.874 | 89.7% | p = 0.075 |
Trunk | 25 | 76.6% | 58.3% | 74.4% | |||
Tumor depth | |||||||
Superficial | 62 | 94.2% | p < 0.001* | 82.3% | p < 0.001* | 95.7% | p < 0.01* |
Deep | 71 | 71.0% | 45.7% | 77.4% | |||
Tumor size | |||||||
≦5 cm | 46 | 100.0% | p < 0.001* | 90.8% | p < 0.001* | 100.0% | p < 0.01* |
>5 cm | 87 | 71.6% | 48.1% | 78.1% | |||
Histological invasion | |||||||
Yes | 52 | 69.6% | p = 0.01* | 41.3% | p < 0.001* | 77.8% | p = 0.025* |
No | 81 | 90.3% | 77.5% | 92.1% | |||
Adjuvant radiotherapy | |||||||
Yes | 32 | 76.5% | p = 0.964 | 57.1% | p = 0.538 | 78.7% | p = 0.128 |
No | 101 | 84.7% | 66.1% | 90.1% | |||
Adjuvant chemotherapy | |||||||
Yes | 28 | 88.0% | p = 0.596 | 66.2% | p = 0.952 | 91.8% | p = 0.625 |
No | 105 | 81.3% | 63.4% | 86.0% |